Back
Garmin Vs. NovoCure Industry Stock Comparison
Buy
59
GRMN
Garmin
Last Price:
$200.73
Seasonality Move:
6.83%
Sell
40
NVCR
NovoCure
Last Price:
$17.77
Seasonality Move:
11%
Sell
40
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRMN Stock Price Chart
GRMN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.5 | Buy |
Relative Strength Index (14 RSI): | 57.51 | Buy |
Chaikin Money Flow: | -156831 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (188.66 - 201.3) | Buy |
Bollinger Bands (100): | (195.06 - 220.64) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 53.74 | Buy |
Chaikin Money Flow: | 752352 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.54 - 18.4) | Buy |
Bollinger Bands (100): | (16.85 - 25.95) | Sell |
GRMN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 200.79 | Buy |
20-day SMA: | 196.22 | Buy |
50-day SMA: | 199.72 | Buy |
200-day SMA: | 196.97 | Buy |
8-day EMA: | 200.97 | Buy |
20-day EMA: | 197.76 | Buy |
50-day EMA: | 200.09 | Buy |
200-day EMA: | 193.8 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.85 | Buy |
20-day SMA: | 17.83 | Buy |
50-day SMA: | 17.89 | Buy |
200-day SMA: | 20.31 | Sell |
8-day EMA: | 17.83 | Buy |
20-day EMA: | 17.69 | Buy |
50-day EMA: | 18.37 | Sell |
200-day EMA: | 20.3 | Sell |
Garmin Earnings Growth & GRMN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.08 per share, an increase this year of $0.93 per share, and an increase next year of $0.65 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.10 per share.
Garmin Technical Analysis
May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |